|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
SCIDIR_on1101966595 |
003 |
OCoLC |
005 |
20231120010353.0 |
006 |
m o d |
007 |
cr cnu|||unuuu |
008 |
190521s2019 enka ob 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d N$T
|d OPELS
|d YDX
|d EBLCP
|d OCLCF
|d UKAHL
|d OCLCQ
|d SNM
|d OCLCQ
|d ERF
|d LVT
|d UX1
|d VT2
|d OCLCO
|d OCLCA
|d NLW
|d OCLCQ
|d OCLCO
|d COM
|d OCL
|d OCLCQ
|d OCLCO
|
015 |
|
|
|a GBB9A2790
|2 bnb
|
019 |
|
|
|a 1102074571
|a 1229874259
|a 1235843511
|
020 |
|
|
|a 9780128153499
|q (electronic bk.)
|
020 |
|
|
|a 0128153490
|q (electronic bk.)
|
020 |
|
|
|z 9780128153482
|
020 |
|
|
|z 0128153482
|
035 |
|
|
|a (OCoLC)1101966595
|z (OCoLC)1102074571
|z (OCoLC)1229874259
|z (OCoLC)1235843511
|
050 |
|
4 |
|a RB155.5
|b .N66 2019
|
060 |
|
4 |
|a 2019 F-959
|
060 |
|
4 |
|a QS 675
|
072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
082 |
0 |
4 |
|a 616/.042
|2 23
|
245 |
0 |
0 |
|a Noonan Syndrome :
|b characteristics and interventions /
|c edited by Amrit Bhangoo.
|
250 |
|
|
|a First edition.
|
264 |
|
1 |
|a London :
|b Academic Press, an imprint of Elsevier,
|c [2019]
|
264 |
|
4 |
|c �2019
|
300 |
|
|
|a 1 online resource :
|b illustrations (some color)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
588 |
0 |
|
|a Online resource; title from PDF title page (EBSCO, viewed May 22, 2019).
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a 1. Growth Failure and Experience with Growth Hormone therapy in Noonan Syndrome 2. Cardiac Manifestations in Noonan Syndrome; Effects of Growth hormone therapy 3. Noonan Syndrome: Phenotypic Variations and Molecular Genetics 4. Urological Conditions and Treatment in Noonan Syndrome 5. Noonan Syndrome: Gastroenterology System Challenges 6. Developmental and Neurological features of Noonan Syndrome 7. Hemostatic and Coagulation Factor deficiency in Noonan Syndrome 8. Peri-Operative Considerations in Noonan Syndrome
|
650 |
|
0 |
|a Genetic disorders.
|
650 |
|
0 |
|a Genetic disorders in children.
|
650 |
|
0 |
|a Genetic disorders
|x Treatment.
|
650 |
|
0 |
|a Genetic disorders in children
|x Treatment.
|
650 |
|
0 |
|a Comorbidity.
|
650 |
1 |
2 |
|a Noonan Syndrome
|x diagnosis
|0 (DNLM)D009634Q000175
|
650 |
2 |
2 |
|a Noonan Syndrome
|x therapy
|0 (DNLM)D009634Q000628
|
650 |
2 |
2 |
|a Comorbidity
|0 (DNLM)D015897
|
650 |
|
2 |
|a Genetic Diseases, Inborn
|0 (DNLM)D030342
|
650 |
|
6 |
|a Maladies g�en�etiques.
|0 (CaQQLa)201-0024547
|
650 |
|
6 |
|a Maladies g�en�etiques chez l'enfant.
|0 (CaQQLa)201-0042664
|
650 |
|
6 |
|a Maladies g�en�etiques
|0 (CaQQLa)201-0024547
|x Traitement.
|0 (CaQQLa)201-0377521
|
650 |
|
6 |
|a Maladies g�en�etiques chez l'enfant
|0 (CaQQLa)201-0042664
|x Traitement.
|0 (CaQQLa)201-0377521
|
650 |
|
6 |
|a Comorbidit�e.
|0 (CaQQLa)201-0319011
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
650 |
|
7 |
|a Comorbidity
|2 fast
|0 (OCoLC)fst00871254
|
650 |
|
7 |
|a Genetic disorders
|2 fast
|0 (OCoLC)fst00940009
|
650 |
|
7 |
|a Genetic disorders in children
|2 fast
|0 (OCoLC)fst00940025
|
650 |
|
7 |
|a Genetic disorders
|x Treatment
|2 fast
|0 (OCoLC)fst00940023
|
700 |
1 |
|
|a Bhangoo, Amrit,
|e editor.
|
776 |
0 |
8 |
|i Print version:
|t Noonan Syndrome.
|b First edition.
|d London : Academic Press, an imprint of Elsevier, [2019]
|z 0128153482
|z 9780128153482
|w (OCoLC)1078767855
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128153482
|z Texto completo
|